1. Sharaiha RZ, Shikora S, White KP, et al. Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol. 2023. 57(10):967-976. doi: 10.1097/MCG.0000000000001916.
2. Haam JH, Kim BT, Kim EM, et al. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023 Jun 30;32(2):121-129. doi: 10.7570/jomes23031.
3. van der Valk ES, van den Akker ELT, Savas M, Kleinendorst L, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev. 2019 Jun;20(6):795-804. doi: 10.1111/obr.12836.
4. Cornier MA. A review of current guidelines for the treatment of obesity. Am J Manag Care. 2022 Dec;28(15 Suppl):S288-S296. doi: 10.37765/ajmc.2022.89292.
5. FDA. WEGOVY (semaglutide) injection, for subcutaneous use. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
6. Medscape. Semaglutide (Rx): Dosing & Uses. 2025. https://reference.medscape.com/drug/ozempic-rybelsus-wegovy-semaglutide-1000174
7. FDA. FDA Approves New Drug Treatment for Chronic Weight Management, First since 2014. 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
8. ASHP. Metformin. 2024. https://www.drugs.com/monograph/metformin.html
9. TGA. Australian Public Assessment Report for Semaglutide. 2020. https://www.tga.gov.au/sites/default/files/auspar-semaglutide-201030.pdf.
10. Medscape.com. Orlistat (Rx, OTC). 2025. https://reference.medscape.com/drug/alli-xenical-orlistat-342068#0
11. TGA. Prescribing medicine in pregnancy database. 2025. https://www.tga.gov.au/products/medicines/find-information-about-medicine/prescribing-medicines-pregnancy-database
12. ASHP. Semaglutide. 2024. https://www.drugs.com/monograph/semaglutide.html
13. ASHP. Orlistat. 2024. https://www.drugs.com/monograph/orlistat.html
14. Seifarth C, Schehler B, Schneider H. Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity. Exp Clin Endocrinol Diabetes. 2013;121:27-31.
15. Fontbonne A, Diouf I, Baccara-Dinet M, et al. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial. Diabetes Metab. 2009 Nov;35(5):385-91.